NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 77 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2013. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $38,710,000 | -47.6% | 29,106 | -10.2% | 0.00% | – |
| Q3 2015 | $73,924,000 | +266.2% | 32,423 | +158.6% | 0.00% | – |
| Q2 2015 | $20,188,000 | +251.6% | 12,539 | +247.2% | 0.00% | – |
| Q1 2015 | $5,741,000 | -58.9% | 3,611 | -65.9% | 0.00% | – |
| Q3 2014 | $13,983,000 | +376.7% | 10,593 | +434.5% | 0.00% | – |
| Q2 2014 | $2,933,000 | +372.3% | 1,982 | +432.8% | 0.00% | – |
| Q1 2014 | $621,000 | -83.3% | 372 | -79.3% | 0.00% | – |
| Q4 2013 | $3,712,000 | -95.7% | 1,793 | -94.5% | 0.00% | – |
| Q3 2013 | $87,066,000 | -22.9% | 32,855 | -22.3% | 0.00% | – |
| Q2 2013 | $112,888,000 | – | 42,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Platinum Management (NY) LLC | 15,046,431 | $19,861,000 | 4.55% |
| COMMERZBANK AKTIENGESELLSCHAFT /FI | 6,702,002 | $8,847,000 | 0.04% |
| LifePlan Financial Group, Inc | 28,810 | $38,000 | 0.03% |
| Hudock, Inc. | 27,500 | $36,000 | 0.02% |
| NOMURA HOLDINGS INC | 4,631,059 | $6,250,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 491,780 | $649,000 | 0.02% |
| Stratos Wealth Partners, LTD. | 45,535 | $60,000 | 0.01% |
| LYNCH & ASSOCIATES/IN | 18,000 | $24,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 71,463 | $94,000 | 0.01% |
| SII INVESTMENTS INC/WI | 63,115 | $83,000 | 0.01% |